ePrints

Prescribing in pregnancy

Lookup NU author(s): Sally Stephens, Dr Kenneth Hodson, Professor Simon ThomasORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Most drugs can cross the placenta and some of these have adverse foetal effects. Organogenesis occurs between 18 days and 10 weeks of gestation and this is the highest risk period for teratogenic effects. However, later exposure may cause growth or developmental effects while exposure near term may be associated with neonatal toxicity or withdrawal syndromes. This article provides an update on prescribing during pregnancy, concentrating on the management of hypertension, hypercholesterolaemia, diabetes, epilepsy and depression, as well as treatments for autoimmune disease and organ transplantation. © 2009 Elsevier Ltd. All rights reserved.

Publication metadata

Author(s): Stephens S, Hodson K, Thomas S

Publication type: Article

Publication status: Published

Journal: Medicine

Year: 2009

Volume: 37

Issue: 9

Pages: 500-505

ISSN (print): 1357-3039

ISSN (electronic): 1365-4357

Publisher: The Medicine Publishing Company

URL: http://dx.doi.org/10.1016/j.mpmed.2009.03.010

DOI: 10.1016/j.mpmed.2009.03.010

Altmetrics

Share